Company profile ACAD
After 39 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 52 days it will total up to 100.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 105 | 124 18.1% QoQ | 195 57.3% QoQ | 223 14.4% QoQ |
| 2020 | 197 87.6% YoY -11.7% QoQ | 201 62.1% YoY 2.0% QoQ | 303 55.4% YoY 50.7% QoQ | 254 13.9% YoY -16.2% QoQ |
| 2021 | 367 86.3% YoY 44.5% QoQ | 218 8.5% YoY -40.6% QoQ | 138 -54.5% YoY -36.7% QoQ | 128 -49.6% YoY -7.2% QoQ |
| 2022 | 159 -56.7% YoY 24.2% QoQ | 159 -27.1% YoY 0.0% QoQ | 124 -10.1% YoY -22.0% QoQ | 103 -19.5% YoY -16.9% QoQ |
| 2023 | 154 -3.1% YoY 49.5% QoQ | 140 -11.9% YoY -9.1% QoQ | 121 -2.4% YoY -13.6% QoQ | 121 17.5% YoY 0.0% QoQ |
| 2024 | 43 -72.1% YoY -64.5% QoQ | - | - | - |
The average 5 years interest of ACADIA Pharmaceuticals was 13.7 per week. The last year interest of ACADIA Pharmaceuticals compared to the last 5 years has changed by -26.72%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -28.69%.
There is not enough data for ACADIA Pharmaceuticals NUPLAZID to provide analysis
There is not enough data for ACADIA Pharmaceuticals NUPLAZID to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals NUPLAZID to provide analysis
There is not enough data for ACADIA Pharmaceuticals Parkinson's treatment to provide analysis
There is not enough data for ACADIA Pharmaceuticals Parkinson's treatment to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals Parkinson's treatment to provide analysis
There is not enough data for ACADIA Pharmaceuticals CNS disorders to provide analysis
There is not enough data for ACADIA Pharmaceuticals CNS disorders to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals CNS disorders to provide analysis
There is not enough data for ACADIA Pharmaceuticals rare diseases to provide analysis
There is not enough data for ACADIA Pharmaceuticals rare diseases to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals rare diseases to provide analysis
There is not enough data for ACADIA Pharmaceuticals Phase III study to provide analysis
There is not enough data for ACADIA Pharmaceuticals Phase III study to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals Phase III study to provide analysis
After 39 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 52 days it will total up to 56.0. ACADIA Pharmaceuticals careers expected interest is significantly lower compared to previous quarter (-63.6%) and same quarter last year (-56.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 110 | 230 109.1% QoQ | 60 -73.9% QoQ | 131 118.3% QoQ |
| 2020 | 108 -1.8% YoY -17.6% QoQ | 102 -55.7% YoY -5.6% QoQ | 50 -16.7% YoY -51.0% QoQ | 232 77.1% YoY 364.0% QoQ |
| 2021 | 184 70.4% YoY -20.7% QoQ | 49 -52.0% YoY -73.4% QoQ | 23 -54.0% YoY -53.1% QoQ | 66 -71.6% YoY 187.0% QoQ |
| 2022 | 22 -88.0% YoY -66.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 30 30.4% YoY inf% QoQ | 224 239.4% YoY 646.7% QoQ |
| 2023 | 128 481.8% YoY -42.9% QoQ | 153 inf% YoY 19.5% QoQ | 50 66.7% YoY -67.3% QoQ | 154 -31.2% YoY 208.0% QoQ |
| 2024 | 24 -81.2% YoY -84.4% QoQ | - | - | - |
The average 5 years interest of ACADIA Pharmaceuticals careers was 8.16 per week. The last year interest of ACADIA Pharmaceuticals careers compared to the last 5 years has changed by 12.62%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -21.52%.
There is not enough data for ACADIA Pharmaceuticals review to provide analysis
There is not enough data for ACADIA Pharmaceuticals review to provide correlation calculation
There is not enough data for ACADIA Pharmaceuticals review to provide analysis
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. ACADIA Pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 308 inf% YoY inf% QoQ | 215 inf% YoY -30.2% QoQ |
| 2021 | 171 inf% YoY -20.5% QoQ | 128 inf% YoY -25.1% QoQ | 64 -79.2% YoY -50.0% QoQ | 88 -59.1% YoY 37.5% QoQ |
| 2022 | 100 -41.5% YoY 13.6% QoQ | 125 -2.3% YoY 25.0% QoQ | 180 181.2% YoY 44.0% QoQ | 122 38.6% YoY -32.2% QoQ |
| 2023 | 91 -9.0% YoY -25.4% QoQ | 154 23.2% YoY 69.2% QoQ | 124 -31.1% YoY -19.5% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of ACADIA Pharmaceuticals news was 7.16 per week. The last year interest of ACADIA Pharmaceuticals news compared to the last 5 years has changed by 17.6%. This is something to be checked. This didn't exist 5 years ago.
After 39 days of this quarter the interest is at 33.0. Based on that we can calculate that during remaining 52 days it will total up to 77.0. ACADIA Pharmaceuticals -stock -company expected interest is significantly lower compared to same quarter last year (-56.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 107 | 157 46.7% QoQ | 284 80.9% QoQ | 218 -23.2% QoQ |
| 2020 | 210 96.3% YoY -3.7% QoQ | 211 34.4% YoY 0.5% QoQ | 294 3.5% YoY 39.3% QoQ | 200 -8.3% YoY -32.0% QoQ |
| 2021 | 315 50.0% YoY 57.5% QoQ | 180 -14.7% YoY -42.9% QoQ | 140 -52.4% YoY -22.2% QoQ | 148 -26.0% YoY 5.7% QoQ |
| 2022 | 163 -48.3% YoY 10.1% QoQ | 205 13.9% YoY 25.8% QoQ | 196 40.0% YoY -4.4% QoQ | 150 1.4% YoY -23.5% QoQ |
| 2023 | 178 9.2% YoY 18.7% QoQ | 183 -10.7% YoY 2.8% QoQ | 138 -29.6% YoY -24.6% QoQ | 122 -18.7% YoY -11.6% QoQ |
| 2024 | 33 -81.5% YoY -73.0% QoQ | - | - | - |
The average 5 years interest of ACADIA Pharmaceuticals -stock -company was 14.68 per week. The last year interest of ACADIA Pharmaceuticals -stock -company compared to the last 5 years has changed by -23.37%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -30.21%.